Literature DB >> 29943896

Relatively favorable prognosis for MLL-rearranged childhood acute leukemia with reciprocal translocations.

Liu Yang1,2, Lixia Ding2,3, Jianwei Liang2, Jing Chen1,2, YanJing Tang1, Huiliang Xue1, Longjun Gu1, Shuhong Shen1,2, Benshang Li1,4, Jing Chen1,2.   

Abstract

BACKGROUND: Mixed-lineage leukemia (MLL) with multifarious partner genes leads to aggressive leukemia with dismal outcomes.
METHODS: Using panel-based targeted sequencing, we examined 90 cases with MLL-rearranged (MLL-r) childhood acute leukemia, including 55 with acute lymphoblastic leukemia (ALL) and 35 with acute myeloid leukemia (AML).
RESULTS: MLL breakpoints and complete rearrangements were identified. A total of 37.8% (34/90) of patients displayed a single direct MLL fusion gene, 15.6% (14/90) carried a single reciprocal fusion, and 27.8% (25/90) had both reciprocal MLL fusion alleles. The remaining 17 MLL-r cases exhibited complex translocations with homozygous disruptions on chromosome 11 or two breakpoints on the same MLL allele with a deletion of functional regions. A total of 77 patients (45 ALL and 32 AML) received chemotherapy with a median follow-up of 2.5 years. Unexpectedly, we identified children with reciprocal MLL fusions who exhibited relatively favorable outcomes compared with those in children with complex translocations or a single direct MLL fusion allele (66.1% vs. 24.6% and 27.6%, P = 0.001). Reciprocal MLL fusion may be functionally rescued by a partially truncated MLL protein.
CONCLUSION: Comprehensive MLL-r analysis by targeted next-generation sequencing can provide detailed molecular information and is helpful for precise stratified treatment and clinical prognosis determination.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  MLL; acute leukemia; childhood; next-generation sequencing; reciprocal MLL alleles

Mesh:

Substances:

Year:  2018        PMID: 29943896     DOI: 10.1002/pbc.27266

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  3 in total

Review 1.  Novel Targeted Therapeutics in Acute Myeloid Leukemia: an Embarrassment of Riches.

Authors:  Nicole R Grieselhuber; Alice S Mims
Journal:  Curr Hematol Malig Rep       Date:  2021-03-18       Impact factor: 3.952

Review 2.  Genomic Mechanisms Influencing Outcome in Chronic Myeloid Leukemia.

Authors:  Adelina Fernandes; Naranie Shanmuganathan; Susan Branford
Journal:  Cancers (Basel)       Date:  2022-01-26       Impact factor: 6.639

Review 3.  Mature B cell acute lymphoblastic leukaemia with KMT2A-MLLT3 transcripts in children: three case reports and literature reviews.

Authors:  Yinghui Cui; Min Zhou; Pinli Zou; Xin Liao; Jianwen Xiao
Journal:  Orphanet J Rare Dis       Date:  2021-07-30       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.